Study identity card

Kuzubov

Russian Federation
Share
  • Disease: Mpox
  • Study type: Randomised Clinical Trial, Prevention
  • Study type descriptors: Interventional
  • Objective: To assess the immunogenicity, reactogenicity and safety of the VAC?6 vaccine in healthy volunteers aged 18-60 years
  • Number of participants enrolled: 334
  • Study enrolling from to

Study Data

  • Adults (18-64 years)
  • General population
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • VAC∆6

Other information

Funders/Sponsors:

  • Federal Budgetary Research Institution State Research Center of Virology and Biotechnology “Vector”

The information was provided with the aid of the study investigators

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to